EX-99.1
Published on November 4, 2025
Bowhead Specialty Holdings Inc. Reports Third Quarter 2025 Results
NEW YORK, New York. (BusinessWire) – Bowhead Specialty Holdings Inc. (NYSE: BOW), a specialty lines insurance group focused on providing casualty, professional liability and healthcare liability insurance products, today announced financial results for the third quarter ended September 30, 2025.(1)
Third Quarter 2025 Highlights
•Gross written premiums increased 17.5% to $231.5 million.
•Net income of $15.2 million, or $0.45 per diluted share.
•Adjusted net income(2) of $15.8 million, or $0.47 per diluted share(2).
•Return on equity of 14.5% and adjusted return on equity(2) of 15.1%.
•Book value per share $13.15 and diluted book value per share of $12.75.
Bowhead Chief Executive Officer, Stephen Sills, commented, “Bowhead delivered another excellent quarter highlighted by consistent strong top and bottom line growth. Gross written premiums in the third quarter grew 17.5% year-over-year and adjusted net income grew 25.5%. We achieved adjusted return on equity of 15.1% and diluted adjusted earnings per share of $0.47. These results are a testament to our disciplined approach to underwriting, the continued expansion of our “craft” and “flow” underwriting operations, and our commitment to operational excellence. Collectively, these results reinforce what I’ve said in the past: Bowhead is a franchise built for enduring success and cross-cycle profitability.”
Underwriting Results
The 17.5% increase in gross written premiums to $231.5 million in the third quarter of 2025 was driven by our increasing renewal book and continued growth in our platform across all divisions:
•Our Casualty division led the growth with a 20.4% increase to $144.7 million;
•Professional Liability increased 1.7% to $45.7 million;
•Healthcare Liability increased 11.1% to $34.8 million;
•Baleen Specialty increased 83.4% from the previous quarter to $6.2 million.
Our loss ratio of 65.9% in the third quarter of 2025 increased 1.4 points compared to 64.5% in the third quarter of 2024.
The 0.3 point increase in our current accident year loss ratio was driven by changes in our portfolio mix. During the three months ended September 30, 2025, our Casualty division, which has comparatively higher current accident year industry loss ratios, comprised a larger proportion of our net earned premiums compared to the prior period.
The remaining 1.1 point increase in our prior accident year loss ratio was due to expected loss ratios applied to audit premiums fully earned in the quarter but associated with prior accident years. This increase was not based on actual losses settling for more than reserved, and did not represent an increase in estimated reserves on unresolved claims.
Our expense ratio was 29.5% for the three months ended September 30, 2025, reflecting a decrease of 0.4 points compared to 29.9% for the same period in 2024. This decrease in our expense ratio was primarily driven by the 1.2 point decrease in our operating expenses ratio and a 0.3 point increase in other insurance-related income, which contributed to the lowering of our expense ratio. These improvements were partially offset by the 1.1 point increase in our net acquisition costs ratio.
The decrease in our operating expenses ratio was due to the continued scaling of our business, where net earned premiums grew at a higher rate than our expenses, as well as the prudent management of our expenses.
The increase in our net acquisition costs ratio was driven by an increase in the ceding fee we pay to American Family and, to a lesser extent, earned broker commissions due to changes in our portfolio mix.
Investment Results
Net investment income increased 30.9% in the quarter to $15.0 million, driven by a higher balance of investments and higher yields on invested assets. Our investment portfolio had a book yield of 4.8% and a new money rate of 4.6% as of September 30, 2025.
The weighted average effective duration of our investment portfolio, which included cash equivalents, was 2.9 years and had an average rating of “AA” as of September 30, 2025.
__________________
(1)Comparisons in this release are made to September 30, 2024 financial results unless otherwise noted.
(2)Non-GAAP financial measure. See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of the non-GAAP financial measures to their most directly comparable U.S. GAAP measures.
Summary of Operating Results
The following table summarizes the Company’s results of operations for the three and nine months ended September 30, 2025 and 2024:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||
| 2025 | 2024 | % Change | 2025 | 2024 | % Change | ||||||||||||||||||||||||||||||
| ($ in thousands, except percentages and per share data) | |||||||||||||||||||||||||||||||||||
| Gross written premiums | $ | 231,515 | $ | 196,976 | 17.5 | % | $ | 638,724 | $ | 510,948 | 25.0 | % | |||||||||||||||||||||||
| Ceded written premiums | (82,492) | (68,643) | 20.2 | % | (224,079) | (179,710) | 24.7 | % | |||||||||||||||||||||||||||
| Net written premiums | $ | 149,023 | $ | 128,333 | 16.1 | % | $ | 414,645 | $ | 331,238 | 25.2 | % | |||||||||||||||||||||||
Revenues | |||||||||||||||||||||||||||||||||||
Net earned premiums | $ | 128,407 | $ | 105,180 | 22.1 | % | $ | 357,360 | $ | 278,247 | 28.4 | % | |||||||||||||||||||||||
| Net investment income | 15,038 | 11,491 | 30.9 | % | 41,274 | 27,928 | 47.8 | % | |||||||||||||||||||||||||||
| Net realized investment losses | (15) | (18) | (16.7) | % | (30) | (16) | 87.5 | % | |||||||||||||||||||||||||||
Other insurance-related income | 502 | 108 | 364.8 | % | 1,307 | 171 | 664.3 | % | |||||||||||||||||||||||||||
Total revenues | 143,932 | 116,761 | 23.3 | % | 399,911 | 306,330 | 30.5 | % | |||||||||||||||||||||||||||
| Expenses | |||||||||||||||||||||||||||||||||||
Net losses and loss adjustment expenses | 84,608 | 67,824 | 24.7 | % | 236,935 | 181,162 | 30.8 | % | |||||||||||||||||||||||||||
| Net acquisition costs | 12,512 | 9,163 | 36.5 | % | 33,346 | 23,267 | 43.3 | % | |||||||||||||||||||||||||||
| Operating expenses | 25,837 | 22,386 | 15.4 | % | 75,623 | 65,761 | 15.0 | % | |||||||||||||||||||||||||||
| Non-operating expenses | 783 | 487 | 60.8 | % | 1,330 | 2,185 | (39.1) | % | |||||||||||||||||||||||||||
| Warrant expense | 792 | 792 | — | % | 2,350 | 1,125 | 108.9 | % | |||||||||||||||||||||||||||
| Credit facility interest expenses and fees | 262 | 252 | 4.0 | % | 770 | 477 | 61.4 | % | |||||||||||||||||||||||||||
| Foreign exchange losses | 32 | 37 | (13.5) | % | 64 | 67 | (4.5) | % | |||||||||||||||||||||||||||
Total expenses | 124,826 | 100,941 | 23.7 | % | 350,418 | 274,044 | 27.9 | % | |||||||||||||||||||||||||||
Income before income taxes | 19,106 | 15,820 | 20.8 | % | 49,493 | 32,286 | 53.3 | % | |||||||||||||||||||||||||||
Income tax expense | (3,930) | (3,728) | 5.4 | % | (10,550) | (7,649) | 37.9 | % | |||||||||||||||||||||||||||
Net income | $ | 15,176 | $ | 12,092 | 25.5 | % | $ | 38,943 | $ | 24,637 | 58.1 | % | |||||||||||||||||||||||
| Key Operating and Financial Metrics: | |||||||||||||||||||||||||||||||||||
Adjusted net income(1) | $ | 15,832 | $ | 12,520 | 26.5 | % | $ | 40,068 | $ | 28,588 | 40.2 | % | |||||||||||||||||||||||
| Loss ratio | 65.9 | % | 64.5 | % | 66.3 | % | 65.1 | % | |||||||||||||||||||||||||||
| Expense ratio | 29.5 | % | 29.9 | % | 30.1 | % | 31.9 | % | |||||||||||||||||||||||||||
| Combined ratio | 95.4 | % | 94.4 | % | 96.4 | % | 97.0 | % | |||||||||||||||||||||||||||
Return on equity(2) | 14.5 | % | 13.7 | % | 13.0 | % | 11.8 | % | |||||||||||||||||||||||||||
Adjusted return on equity(1)(2) | 15.1 | % | 14.2 | % | 13.3 | % | 13.7 | % | |||||||||||||||||||||||||||
| Diluted earnings per share | $ | 0.45 | $ | 0.36 | 25.0 | % | $ | 1.15 | $ | 0.87 | 32.2 | % | |||||||||||||||||||||||
Diluted adjusted earnings per share(1) | $ | 0.47 | $ | 0.38 | 23.7 | % | $ | 1.19 | $ | 1.01 | 17.8 | % | |||||||||||||||||||||||
__________________
NM - Percentage change is not meaningful.
(1)Non-GAAP financial measure. See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of the non-GAAP financial measures to their most directly comparable U.S. GAAP measures.
(2)For the the three and nine months ended September 30, 2025 and 2024, net income and adjusted net income are annualized to arrive at return on equity and adjusted return on equity.
Condensed Consolidated Balance Sheets
| September 30, 2025 | December 31, 2024 | ||||||||||
| ($ in thousands, except share data) | |||||||||||
| Assets | |||||||||||
| Investments | |||||||||||
Fixed maturity securities, available for sale, at fair value (amortized cost of $1,143,594 and $894,145, respectively) | $ | 1,149,598 | $ | 879,989 | |||||||
| Short-term investments, at amortized cost, which approximates fair value | — | 9,997 | |||||||||
Total investments | 1,149,598 | 889,986 | |||||||||
| Cash and cash equivalents | 197,855 | 97,476 | |||||||||
| Restricted cash and cash equivalents | 52,921 | 124,582 | |||||||||
| Accrued investment income | 8,893 | 7,520 | |||||||||
| Premium balances receivable | 66,104 | 63,672 | |||||||||
| Reinsurance recoverable, net | 360,877 | 255,072 | |||||||||
| Prepaid reinsurance premiums | 184,560 | 152,567 | |||||||||
| Deferred policy acquisition costs | 33,470 | 27,625 | |||||||||
| Property and equipment, net | 9,683 | 6,845 | |||||||||
| Income taxes receivable | 3,345 | 586 | |||||||||
| Deferred tax assets, net | 19,093 | 20,340 | |||||||||
| Other assets | 8,150 | 7,971 | |||||||||
Total assets | $ | 2,094,549 | $ | 1,654,242 | |||||||
| Liabilities | |||||||||||
| Reserve for losses and loss adjustment expenses | $ | 1,035,171 | $ | 756,859 | |||||||
| Unearned premiums | 536,108 | 446,850 | |||||||||
| Reinsurance balances payable | 67,879 | 51,856 | |||||||||
| Income taxes payable | 136 | 1,571 | |||||||||
| Accrued expenses | 14,384 | 18,010 | |||||||||
| Other liabilities | 9,834 | 8,654 | |||||||||
Total liabilities | 1,663,512 | 1,283,800 | |||||||||
| Commitments and contingencies (Note 12) | |||||||||||
| Mezzanine equity | |||||||||||
| Performance stock units | 808 | 265 | |||||||||
| Stockholders' equity | |||||||||||
| Common stock | 328 | 327 | |||||||||
($0.01 par value; 400,000,000 shares authorized, 32,782,974 and 32,662,683 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively) | |||||||||||
| Additional paid-in capital | 323,306 | 318,095 | |||||||||
Accumulated other comprehensive gain (loss) | 4,743 | (11,154) | |||||||||
| Retained earnings | 101,852 | 62,909 | |||||||||
| Total stockholders' equity | 430,229 | 370,177 | |||||||||
| Total mezzanine equity and stockholders' equity | 431,037 | 370,442 | |||||||||
Total liabilities, mezzanine equity and stockholders' equity | $ | 2,094,549 | $ | 1,654,242 | |||||||
Gross Written Premiums
The following tables present gross written premiums by underwriting division for the three and nine months ended September 30, 2025 and 2024:
| Three Months Ended September 30, | |||||||||||||||||||||||||||||||||||
| 2025 | % of Total | 2024 | % of Total | $ Change | % Change | ||||||||||||||||||||||||||||||
| ($ in thousands, except percentages) | |||||||||||||||||||||||||||||||||||
| Casualty | $ | 144,727 | 62.5 | % | $ | 120,223 | 61.0 | % | $ | 24,504 | 20.4 | % | |||||||||||||||||||||||
| Professional Liability | 45,739 | 19.7 | % | 44,962 | 22.9 | % | 777 | 1.7 | % | ||||||||||||||||||||||||||
| Healthcare Liability | 34,844 | 15.1 | % | 31,358 | 15.9 | % | 3,486 | 11.1 | % | ||||||||||||||||||||||||||
| Baleen Specialty | 6,205 | 2.7 | % | 433 | 0.2 | % | 5,772 | 1333.0 | % | ||||||||||||||||||||||||||
Gross written premiums | $ | 231,515 | 100.0 | % | $ | 196,976 | 196976333 | 100.0 | % | $ | 34,539 | 17.5 | % | ||||||||||||||||||||||
| Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||
| 2025 | % of Total | 2024 | % of Total | $ Change | % Change | ||||||||||||||||||||||||||||||
| ($ in thousands, except percentages) | |||||||||||||||||||||||||||||||||||
| Casualty | $ | 417,762 | 65.4 | % | $ | 325,945 | 63.8 | % | $ | 91,817 | 28.2 | % | |||||||||||||||||||||||
| Professional Liability | 126,491 | 19.8 | % | 114,641 | 22.4 | % | 11,850 | 10.3 | % | ||||||||||||||||||||||||||
| Healthcare Liability | 82,136 | 12.9 | % | 69,920 | 13.7 | % | 12,216 | 17.5 | % | ||||||||||||||||||||||||||
| Baleen Specialty | 12,335 | 1.9 | % | 442 | 0.1 | % | 11,893 | 2690.7 | % | ||||||||||||||||||||||||||
Gross written premiums | $ | 638,724 | 100.0 | % | $ | 510,948 | 100.0 | % | $ | 127,776 | 25.0 | % | |||||||||||||||||||||||
Loss Ratio
The following tables summarize current and prior accident year loss ratios for the three and nine months ended September 30, 2025 and 2024:
| Three Months Ended September 30, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| Net Losses and Loss Adjustment Expenses | % of Net Earned Premiums | Net Losses and Loss Adjustment Expenses | % of Net Earned Premiums | ||||||||||||||||||||
| ($ in thousands, except percentages) | |||||||||||||||||||||||
Current accident year | $ | 83,158 | 64.8 | % | $ | 67,824 | 64.5 | % | |||||||||||||||
| Prior accident year | 1,450 | 1.1 | % | — | — | % | |||||||||||||||||
Total | $ | 84,608 | 65.9 | % | $ | 67,824 | 64.5 | % | |||||||||||||||
| Nine Months Ended September 30, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| Net Losses and Loss Adjustment Expenses | % of Net Earned Premiums | Net Losses and Loss Adjustment Expenses | % of Net Earned Premiums | ||||||||||||||||||||
| ($ in thousands, except percentages) | |||||||||||||||||||||||
Current accident year | $ | 234,926 | 65.7 | % | $ | 181,162 | 65.1 | % | |||||||||||||||
| Prior accident year | 2,009 | 0.6 | % | — | — | % | |||||||||||||||||
Total | $ | 236,935 | 66.3 | % | $ | 181,162 | 65.1 | % | |||||||||||||||
Expense Ratio
The following tables summarize the components of our expense ratio for the three and nine months ended September 30, 2025 and 2024:
| Three Months Ended September 30, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| Expenses | % of Net Earned Premiums | Expenses | % of Net Earned Premiums | ||||||||||||||||||||
| ($ in thousands, except percentages) | |||||||||||||||||||||||
Net acquisition costs | $ | 12,512 | 9.8 | % | $ | 9,163 | 8.7 | % | |||||||||||||||
Operating expenses | 25,837 | 20.1 | % | 22,386 | 21.3 | % | |||||||||||||||||
| Less: Other insurance related-income | (502) | (0.4) | % | (108) | (0.1) | % | |||||||||||||||||
| Total | $ | 37,847 | 29.5 | % | $ | 31,441 | 29.9 | % | |||||||||||||||
| Nine Months Ended September 30, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| Expenses | % of Net Earned Premiums | Expenses | % of Net Earned Premiums | ||||||||||||||||||||
| ($ in thousands, except percentages) | |||||||||||||||||||||||
Net acquisition costs | $ | 33,346 | 9.3 | % | $ | 23,267 | 8.4 | % | |||||||||||||||
Operating expenses | 75,623 | 21.2 | % | 65,761 | 23.6 | % | |||||||||||||||||
| Less: Other insurance-related income | (1,307) | (0.4) | % | (171) | (0.1) | % | |||||||||||||||||
| Total | $ | 107,662 | 30.1 | % | $ | 88,857 | 31.9 | % | |||||||||||||||
Net Investment Income
The following table summarizes the sources of net investment income for the three and nine months ended September 30, 2025 and 2024:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| ($ in thousands) | |||||||||||||||||||||||
| U.S. government and government agency | $ | 1,562 | $ | 3,793 | $ | 5,040 | $ | 11,316 | |||||||||||||||
| State and municipal | 1,058 | 467 | 2,621 | 1,241 | |||||||||||||||||||
| Commercial mortgage-backed securities | 1,417 | 761 | 3,864 | 1,603 | |||||||||||||||||||
| Residential mortgage-backed securities | 3,489 | 1,955 | 9,157 | 4,118 | |||||||||||||||||||
| Asset-backed securities | 1,673 | 719 | 4,725 | 1,760 | |||||||||||||||||||
| Corporate | 4,716 | 1,611 | 12,212 | 3,614 | |||||||||||||||||||
| Short-term investments | — | 134 | 214 | 350 | |||||||||||||||||||
| Cash and cash equivalents | 1,421 | 2,273 | 4,280 | 4,493 | |||||||||||||||||||
Gross investment income | 15,336 | 11,713 | 42,113 | 28,495 | |||||||||||||||||||
| Investment expenses | (298) | (222) | (839) | (567) | |||||||||||||||||||
Net investment income | $ | 15,038 | $ | 11,491 | $ | 41,274 | $ | 27,928 | |||||||||||||||
Reconciliation of Non-GAAP Financial Measures
This earnings release contains certain financial measures that are not presented in accordance with generally
accepted accounting principles in the United States (“U.S. GAAP”). We use these non-GAAP financial measures
when planning, monitoring and evaluating our performance. Management believes that each of the non-GAAP
financial measures described below provides useful insight into our underlying business performance.
•Adjusted net income is defined as net income excluding the impact of net realized investment losses, non-operating expenses, foreign exchange losses, and certain strategic initiatives. Adjusted net income excludes the impact of certain items that may not be indicative of underlying business trends, operating results, or future outlook, net of tax impact. We calculate the tax impact only on adjustments that would be included in calculating our income tax expense using the estimated tax rate at which we received a deduction for these adjustments.
•Adjusted return on equity is defined as adjusted net income as a percentage of average beginning and ending mezzanine equity and stockholders’ equity.
•Diluted adjusted earnings per share is defined as adjusted net income divided by the weighted average common shares outstanding for the period, reflecting the dilution that may occur if equity based awards are converted into common stock equivalents as calculated using the treasury stock method.
You should not rely on these non-GAAP financial measures as a substitute for any U.S. GAAP financial measure.
While we believe that these non-GAAP financial measures are useful in evaluating our business, this information
should be considered supplemental in nature and not as a replacement for or superior to the comparable U.S. GAAP
measures. In addition, other companies, including companies in our industry, may calculate such measures
differently, which reduces their usefulness as comparative measures.
Adjusted net income
Adjusted net income for the three and nine months ended September 30, 2025 and 2024 reconciles to net income as follows:
| Three Months Ended September 30, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| Before income taxes | After income taxes | Before income taxes | After income taxes | ||||||||||||||||||||
| ($ in thousands) | |||||||||||||||||||||||
| Income as reported | $ | 19,106 | $ | 15,176 | $ | 15,820 | $ | 12,092 | |||||||||||||||
| Adjustments: | |||||||||||||||||||||||
| Net realized investment losses | 15 | 15 | 18 | 18 | |||||||||||||||||||
| Non-operating expenses | 783 | 783 | 487 | 487 | |||||||||||||||||||
| Foreign exchange losses | 32 | 32 | 37 | 37 | |||||||||||||||||||
| Tax impact | — | (174) | — | (114) | |||||||||||||||||||
Adjusted net income | $ | 19,936 | $ | 15,832 | $ | 16,362 | $ | 12,520 | |||||||||||||||
| Nine Months Ended September 30, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| Before income taxes | After income taxes | Before income taxes | After income taxes | ||||||||||||||||||||
($ in thousands) | |||||||||||||||||||||||
| Income as reported | $ | 49,493 | $ | 38,943 | $ | 32,286 | $ | 24,637 | |||||||||||||||
Adjustments: | |||||||||||||||||||||||
| Net realized investment losses | 30 | 30 | 16 | 16 | |||||||||||||||||||
| Non-operating expenses | 1,330 | 1,330 | 2,185 | 2,185 | |||||||||||||||||||
| Foreign exchange losses | 64 | 64 | 67 | 67 | |||||||||||||||||||
Strategic initiatives(1) | — | — | 2,733 | 2,733 | |||||||||||||||||||
| Tax impact | — | (299) | — | (1,050) | |||||||||||||||||||
Adjusted net income | $ | 50,917 | $ | 40,068 | $ | 37,287 | $ | 28,588 | |||||||||||||||
_________________
(1)Strategic initiatives for the nine months ended September 30, 2024 represents costs incurred to set up our Baleen Specialty division, which is recorded in operating expenses within the Consolidated Statements of Income and Comprehensive Income. The costs incurred primarily represent expenses to implement the new platform and processes supporting the Baleen Specialty division. See “Business— Our Business”
Adjusted return on equity
Adjusted return on equity for the three and nine months ended September 30, 2025 and 2024 reconciles to return on equity as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| ($ in thousands, except percentages) | |||||||||||||||||||||||
Numerator: Adjusted net income(1) | $ | 63,328 | $ | 50,081 | $ | 53,424 | $ | 38,117 | |||||||||||||||
| Denominator: Average mezzanine equity and stockholders' equity | 419,424 | 352,368 | 400,739 | 278,451 | |||||||||||||||||||
| Adjusted return on equity | 15.1 | % | 14.2 | % | 13.3 | % | 13.7 | % | |||||||||||||||
_______________
(1)For the three and nine months ended September 30, 2025 and 2024, net income and adjusted net income are annualized to arrive at return on equity and adjusted return on equity.
Diluted adjusted earnings per share
Diluted adjusted earnings per share for the three and nine months ended September 30, 2025 and 2024 reconciles to diluted earnings per share as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| ($ in thousands, except share and per share data) | |||||||||||||||||||||||
| Numerator: Adjusted net income | $ | 15,832 | $ | 12,520 | $ | 40,068 | $ | 28,588 | |||||||||||||||
| Denominator: Diluted weighted average shares outstanding | 33,650,923 | 33,263,958 | 33,807,105 | 28,352,420 | |||||||||||||||||||
| Diluted adjusted earnings per share | $ | 0.47 | $ | 0.38 | $ | 1.19 | $ | 1.01 | |||||||||||||||
About Bowhead Specialty Holdings Inc.
Bowhead Specialty is a growing specialty insurance business providing casualty, professional liability and healthcare liability insurance products. We were founded and are led by industry veteran Stephen Sills. The team is composed of highly experienced and respected industry veterans with decades of individual, successful underwriting and management experience. We focus on providing “craft” solutions in our specialty lines and classes of business that we believe require deep underwriting and claims expertise in order to produce attractive financial results.
We pride ourselves on the quality and experience of our people, who are committed to exceeding our partners’ expectations through excellent service and expertise. Our collaborative culture spans all functions of our business and allows us to provide a consistent, positive experience for all of our partners.
Conference Call
The Company will host a conference call to discuss its results on the same day, Tuesday, November 4, 2025, beginning at 8:30 a.m. Eastern Time. Interested parties may access the conference call through a live webcast, which can be accessed by going to https://bowhead-3q25-earnings-call.open-exchange.net/registration, or by visiting the Company’s Investor Relations website. A dial-in option for listen-only participants will be available after registering for the call. Please join the live webcast or dial in at least 10 minutes before the start of the call.
A replay of the event webcast will be available on the Company’s Investor Relations website for one year following the call.
Forward-Looking Statements
This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in press release are forward-looking statements. In some cases, forward-looking statements can be identified by terms such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "seeks," "future," "outlook," "prospects" "will," "would," "should," "could," "may," "can have" or similar words. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. These risks include those described in the Company’s filings made with the Securities and Exchange Commission. Forward-looking statements speak only as of the date of this press release and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events or otherwise.
Investor Relations Contact:
Shirley Yap, Head of Investor Relations
investorrelations@bowheadspecialty.com